Semaglutide

Category: Diabetes Drugs CAS No.: 910463-68-2
Pharmaceuticals Active Pharmaceutical Ingredient

General Description

Drug Class: GLP-1 Receptor Agonist

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat Type-2 diabetes. It supports glycaemic control by enhancing glucose-dependent insulin secretion and is supplied as a high-purity active pharmaceutical ingredient.

Beyond glucose regulation, Semaglutide reduces cardiovascular risk in high-risk patients and supports chronic weight management, making it a versatile ingredient for modern metabolic therapies.

Chemical Properties

Appearance
White or off-white powder
Solubility
Soluble in water

Technical Specification

Specific Optical Rotation [α]20D
-15° to -10° (anhydrous and sodium-ion-free substance, C = 10 mg/ml, H2O)
Molecular Ion Mass by MS
4113.58 ± 1.0
HPLC
Retention time of the principal peak of the test solution corresponds to that of the reference solution peak.
Peptide Map
The peptide map of the test solution corresponds to that of the reference solution.

Applications

  • Management of Type-2 diabetes.
  • Reduction of cardiovascular risk in high-risk patients.
  • Treatment of obesity and chronic weight management.

Compliance and Certifications

Manufactured under stringent quality management systems. Full regulatory and quality documentation is available on request.

Packaging Details

Standard Packaging
HDPE Drum

Key Features / Benefits

  • Consistent purity across batches.
  • Reliable, timely supply.

Storage and Handling

  • Store under controlled room temperature at 20°C – 25°C.
  • Prevent sunlight exposure.
  • Protect from moisture.